2014 Annual Meeting | 5MS.004 - Differential Diagnosis of Dementia: Linking Clinical Syndromes to Biomarkers

Date Wednesday 04/30/14

Time 06:30 AM - 08:00 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Morning Seminar

Director(s) Jeffrey M. Burns, MD

Topic(s)

Learning Objectives Participants should understand the basis for the clinical diagnoses of Alzheimer's disease in relation to dementing disorders that often mimic its presentation and should also understand the potential clinical utlility of biofluid and imaging biomarkers for Alzheimer's disease.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Recommended Audience Trainee, General Neurologist, Non-neurologist

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
06:30 AM - 07:00 AM		Introduction to Diagnostic Biomarkers of Alzheimer’s Disease Jeffrey M. Burns, MD, John C. Morris, MD, FAAN
07:00 AM - 08:00 AM		Case Vignettes Illustrating Use of Biomarkers Jeffrey M. Burns, MD, John C. Morris, MD, FAAN

Faculty Disclosures
Jeffrey M. Burns, MD	Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Renew Research. Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Burns has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Norris, Keplinger, Hicks and Welder. The institution of Dr. Burns has received research support from National Institutes of Health. The institution of Dr. Burns has received research support from Biogen. The institution of Dr. Burns has received research support from Eli Lilly. The institution of Dr. Burns has received research support from Amylyx. The institution of Dr. Burns has received research support from Abbvie. The institution of Dr. Burns has received research support from Astra-Zeneca.
John C. Morris, MD, FAAN	Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CBR International Advisory Board. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cure Alzheimers Fund. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LEADS Steering Commitee. The institution of Dr. Morris has received research support from NIH grants. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care. Dr. Morris has received intellectual property interests from a discovery or technology relating to health care.